Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Angiodynamics (ANGO) Non Operating Income (2016 - 2026)

Angiodynamics' Non Operating Income history spans 17 years, with the latest figure at $5.0 million for Q1 2026.

  • For Q1 2026, Non Operating Income fell 10.75% year-over-year to $5.0 million; the TTM value through Feb 2026 reached $3.3 million, down 39.41%, while the annual FY2025 figure was $4.9 million, 705.14% up from the prior year.
  • Non Operating Income reached $5.0 million in Q1 2026 per ANGO's latest filing, up from -$230000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $5.6 million in Q1 2025 to a low of -$1.3 million in Q2 2025.
  • Average Non Operating Income over 5 years is $446882.4, with a median of -$238000.0 recorded in 2024.
  • Peak YoY movement for Non Operating Income: tumbled 2420.0% in 2022, then soared 2438.24% in 2025.
  • A 5-year view of Non Operating Income shows it stood at -$252000.0 in 2022, then surged by 87.3% to -$32000.0 in 2023, then soared by 868.75% to $246000.0 in 2024, then plummeted by 193.5% to -$230000.0 in 2025, then skyrocketed by 2259.57% to $5.0 million in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Non Operating Income are $5.0 million (Q1 2026), -$230000.0 (Q4 2025), and -$178000.0 (Q3 2025).